Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,314,373
  • Shares Outstanding, K 22,206
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,170 K
  • 60-Month Beta 1.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.11
Trade KRYS with:

Options Overview

Details
  • Implied Volatility 74.85%
  • Historical Volatility 43.53%
  • IV Percentile 94%
  • IV Rank 63.22%
  • IV High 111.01% on 11/10/20
  • IV Low 12.70% on 03/17/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 287
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 275

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.75
  • Number of Estimates 3
  • High Estimate -0.61
  • Low Estimate -0.88
  • Prior Year -0.49
  • Growth Rate Est. (year over year) -53.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.04 +15.97%
on 08/19/21
62.43 -5.19%
on 09/02/21
+2.76 (+4.89%)
since 08/17/21
3-Month
51.04 +15.97%
on 08/19/21
72.54 -18.41%
on 07/02/21
-4.30 (-6.77%)
since 06/17/21
52-Week
40.04 +47.83%
on 11/06/20
87.29 -32.19%
on 03/01/21
+12.94 (+27.98%)
since 09/17/20

Most Recent Stories

More News
Krystal Biotech Appoints Laurent Goux as General Manager of Europe

Krystal Biotech, Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced the appointment of Laurent Goux as the General Manager of Europe. Mr. Goux has...

KRYS : 59.19 (+4.78%)
Krystal Biotech to Present Data on DEB and B-VEC at the DEBRA International Conference 2021

-- U.S. FDA has recently approved a compassionate use request for topical B-VEC application to one eye in a RDEB patient

KRYS : 59.19 (+4.78%)
Krystal Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual...

KRYS : 59.19 (+4.78%)
Krystal Biotech Reports Second Quarter 2021 Financial Results and Provides Update on Operational Progress

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today reported financial results and key operational progress updates for the second quarter...

KRYS : 59.19 (+4.78%)
Jeune Aesthetics Announces Initiation of Dosing in Efficacy Cohort of KB301 Phase 1 trial to Assess Improvement in Skin Quality

Jeune Aesthetics, Inc., a wholly-owned subsidiary of Krystal Biotech, Inc., ("Krystal") (NASDAQ: KRYS) today announced the initiation of dosing in the efficacy cohort of the PEARL-1 trial, a Phase 1 multi-dose,...

KRYS : 59.19 (+4.78%)
Relative Strength Alert For Krystal Biotech

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

KRYS : 59.19 (+4.78%)
New Strong Sell Stocks for June 8th

ASLN, CANG, ESLT, GCI, and KRYS have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2021.

GCI : 6.88 (+5.85%)
ESLT : 146.67 (+0.24%)
KRYS : 59.19 (+4.78%)
CANG : 4.32 (+3.10%)
ASLN : 3.22 (+6.27%)
Krystal Biotech to Participate in Upcoming Investor Conferences

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced participation in two upcoming virtual investor conferences.

KRYS : 59.19 (+4.78%)
New Strong Sell Stocks for May 28th

ACET, FURY, KRYS, MRSN, and NBEV have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2021

ACET : 7.19 (+2.13%)
NBEV : 1.3900 (-2.80%)
KRYS : 59.19 (+4.78%)
MRSN : 9.89 (+1.85%)
FURY : 0.6900 (+0.55%)
New Strong Sell Stocks for May 21st

ATHM, INVO, FOUR, KRYS, and RMAX have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2021

RMAX : 31.59 (+1.09%)
ATHM : 42.72 (+1.26%)
KRYS : 59.19 (+4.78%)
INVO : 3.53 (unch)
FOUR : 81.48 (+1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

See More

Key Turning Points

3rd Resistance Point 64.77
2nd Resistance Point 62.26
1st Resistance Point 60.72
Last Price 59.19
1st Support Level 56.67
2nd Support Level 54.16
3rd Support Level 52.62

See More

52-Week High 87.29
Fibonacci 61.8% 69.24
Fibonacci 50% 63.66
Last Price 59.19
Fibonacci 38.2% 58.09
52-Week Low 40.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar